Related Experiment Video
Updated: Dec 25, 2025
06:08
Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
2.3K
A Precision Medicine Approach to Rhinitis Evaluation and Management
Carlos D Crisci1, Ledit R F Ardusso1
1Department of Pulmonology Allergy and Immunology, School of Medicine, National University of Rosario, 2000 Rosario, Santa Fe Argentina.
Current Treatment Options in Allergy
|April 1, 2020
Summary
Precision medicine offers a new approach to rhinitis treatment by identifying specific patient phenotypes and pathways. This strategy enhances diagnosis and enables personalized therapies for allergic rhinitis.
Area of Science:
- Biomedical Science
- Immunology
- Precision Medicine
Background:
- Rhinitis is a common, heterogeneous disease with diverse endotypes and clinical presentations.
- Precision medicine (PM) offers a paradigm shift in disease management through targeted approaches.
- Applying PM principles to rhinitis subtypes can significantly improve patient evaluation and treatment.
Purpose of the Study:
- To review the application of precision medicine principles to rhinitis.
- To highlight advancements in diagnostic tools and therapeutic strategies for rhinitis.
- To emphasize the importance of phenotype classification and biomarker identification.
Main Methods:
- Review of recent clinical trials and technological advancements in rhinitis research.
- Analysis of component-resolved diagnosis (CRD) for allergic rhinitis.
- Evaluation of monoclonal antibody therapies targeting inflammatory pathways.
Main Results:
- Recombinant allergen technology enables molecular characterization of IgE reactivity.
- Component-resolved diagnosis (CRD) enhances precision in allergen immunotherapy for allergic rhinitis.
- Monoclonal antibodies show promising results for various rhinitis endotypes.
Conclusions:
- Understanding pathogenic pathways and accurate phenotyping are crucial for rhinitis management.
- Biomarkers and advanced diagnostic tools facilitate personalized environmental control and pharmacologic options.
- New biological therapies are emerging for rhinitis treatment based on precision medicine approaches.
Related Concept Videos
01:16Drugs Used in Upper Respiratory Disorders: Overview
555
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
555
01:30Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
01:17Drugs Used in Lower Respiratory Disorders: Overview
931
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
931
01:21Rheumatic Heart Disease III: Medical Management
222
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
222
01:30Epistaxis
447
Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
447
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.6K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K